LENZ
LENZ Therapeutics
LENZ
LENZ
55 hedge funds and large institutions have $362M invested in LENZ Therapeutics in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 24 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 20
42% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 24
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1.34M
Holders
55
Holding in Top 10
4
Calls
–
Puts
$1.34M
Top Buyers
| 1 | +$93.3M | |
| 2 | +$80.7M | |
| 3 | +$22.7M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$22.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.3M |
Top Sellers
| 1 | -$2.86M | |
| 2 | -$2.15M | |
| 3 | -$1.54M | |
| 4 |
Renaissance Technologies
New York
|
-$808K |
| 5 |
Morgan Stanley
New York
|
-$699K |